Format

Send to:

Choose Destination
See comment in PubMed Commons below
Nephrol Dial Transplant. 2008 Nov;23(11):3727-9. doi: 10.1093/ndt/gfn332. Epub 2008 Jun 20.

Conversion to sirolimus for chronic renal allograft dysfunction: risk factors for graft loss and severe side effects.

Author information

  • 1Nephrology Department, Hopital Erasme, Université Libre de Bruxelles, Brussels, Belgium. dabram@ulb.ac.be

Abstract

We retrospectively reviewed our experience with 45 kidney transplant recipients (KTR) that were switched from CNI to SRL, mainly for chronic allograft dysfunction (CAD) (41/45). The mean serum creatinine at switch was 2.5 +/- 0.8 mg/dl. At 1 year, patient survival was 93%. Death-censored graft survival was 67% at 1 year and 54% at 2 years. SRL was stopped because of severe side effects in 15 patients. Among these, eight patients developed 'de novo' high-grade proteinuria. Univariate analysis revealed that (1) a higher SRL level at 1 month was a predictor of SRL withdrawal due to severe side effects (P = 0.006), and (2) predictors of graft failure after SRL conversion were low SRL loading dose (P = 0.03) and a higher creatinine level at conversion (P = 0.003). In conclusion, the therapeutic index of SRL in patients suffering from CAD is narrow, with high exposure triggering serious adverse events that may mandate SRL discontinuation, while too low exposure may expose patients to under-immunosuppression and graft loss.

PMID:
18567692
[PubMed - indexed for MEDLINE]
PMCID:
PMC2568008
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk